Transcriptomics

Dataset Information

0

Antileukemic activity of valproic acid in chronic lymphocytic leukemia cells defined by microarray analysis


ABSTRACT: Epigenetic code modifications by histone deacetylase inhibitors (HDACi) have recently been proposed as potential new therapies for hematological malignancies. Chronic Lymphocytic Leukemia (CLL) remains incurable despite the introduction of new treatments. CLL cells are characterized by an apoptosis defect rather than excessive proliferation, but proliferation centers have been found in organs such as bone marrow and lymph nodes. Here, we investigated gene expression modifications in CLL cells following treatment with valproic acid (VPA), a well-tolerated anti-epileptic drug with HDAC inhibitory activity.

ORGANISM(S): Homo sapiens

PROVIDER: GSE14973 | GEO | 2009/08/24

SECONDARY ACCESSION(S): PRJNA111871

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2009-09-17 | E-GEOD-14973 | biostudies-arrayexpress
2016-04-07 | E-MTAB-3764 | biostudies-arrayexpress
2016-12-17 | GSE83530 | GEO
2019-07-20 | E-MTAB-6752 | biostudies-arrayexpress
2012-10-11 | E-GEOD-41441 | biostudies-arrayexpress
2013-03-29 | GSE45610 | GEO
2013-03-29 | E-GEOD-45610 | biostudies-arrayexpress
2015-06-01 | GSE64123 | GEO
2012-10-11 | GSE41441 | GEO
2015-12-08 | E-GEOD-42904 | biostudies-arrayexpress